Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

Next Generation Cardiovascular Drug Development Summit

Evvnt Promotion / evvnt
-
25.04.2023 - 27.04.2023  Hyatt Regency Boston, One Ave. de Lafayette, 02111 Boston, Massachusetts, USA
Time: 9:00 am - 4:00 pm
 
Temi della conferenza
Are you up to date on the latest research and developments in novel biologics to enhance regenerative and precision cardiovascular therapeutics?

Don't miss the Next Generation Cardiovascular Drug Development Summit, coming to Boston on April 25-27 as the only industry-focused meeting dedicated to leveraging novel cell and gene therapies using mRNA, CRISPR/Cas9 and iPSCs for cardiovascular disease.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/1492007-0?pid=4832

Speakers: Christopher O'Donnell, Global Head Cardiovascular and Metabolism Translational Medicine, Novartis Institutes of Biomedical Research, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1492007-1?pid=4832
Ms. Nina Podmore
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Drug Developer - Conference Only: USD 2999.00, Academic and Research - Conference Only: USD 2599.00, Solution Provider - Conference Only: USD 3799.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Österreichische Akademie der ÄrzteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinCharité International AcademyAMREF - African Medical and Research FoundationEuropean Public Health Association (EUPHA)Anästhesie in Entwicklungsländern e. V.Ärztekammer für WienHelix - Forschung & Beratung Wien